Connection

Craig Crosson to Tumor Necrosis Factor-alpha

This is a "connection" page, showing publications Craig Crosson has written about Tumor Necrosis Factor-alpha.
Connection Strength

0.791
  1. Opioid receptor activation: suppression of ischemia/reperfusion-induced production of TNF-a in the retina. Invest Ophthalmol Vis Sci. 2011 Apr; 52(5):2577-83.
    View in: PubMed
    Score: 0.306
  2. Evidence for ceramide induced cytotoxicity in retinal ganglion cells. Exp Eye Res. 2021 10; 211:108762.
    View in: PubMed
    Score: 0.157
  3. Suppression of Acid Sphingomyelinase Protects the Retina from Ischemic Injury. Invest Ophthalmol Vis Sci. 2016 08 01; 57(10):4476-84.
    View in: PubMed
    Score: 0.110
  4. Preservation of retina ganglion cell function by morphine in a chronic ocular-hypertensive rat model. Invest Ophthalmol Vis Sci. 2012 Jun 28; 53(7):4289-98.
    View in: PubMed
    Score: 0.083
  5. Inhibition of histone deacetylase protects the retina from ischemic injury. Invest Ophthalmol Vis Sci. 2010 Jul; 51(7):3639-45.
    View in: PubMed
    Score: 0.071
  6. Latanoprost-induced changes in rat intraocular pressure: direct or indirect? J Ocul Pharmacol Ther. 2008 Aug; 24(4):367-72.
    View in: PubMed
    Score: 0.063
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.